Keywords: sepracor, 1st-qtr, eps, doubles, drugmaker, first-quarter, net
Sepracor's 1st-qtr 2007 EPS more than doubles
Article | 07 May 2007
US drugmaker Sepracor's first-quarter 2007 net income grew to $22.5 million, or $0.19 per share, versus $10.0 million, or $0.09 per share, in the like, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
